Overview

Topiramate and Severe Obesity

Status:
Completed
Trial end date:
2018-01-23
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of Topiramate on the decrease of Body Mass Index compared to placebo at 9 months.
Phase:
Phase 3
Details
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Treatments:
Topiramate